On May 9, 2024, Stavros Vizirgianakis announced that it has entered into letter agreement with Apyx Medical Corporation, pursuant to and immediately upon execution of the Letter Agreement, the Company agreed to appoint Vizirgianakis to its Board of Directors filling a vacancy created by the resignation and retirement of Andrew Makrides and agreed to appoint Vizirgianakis as Chair of the Board, and the Company further agreed to cause the slate of director nominees standing for election and recommended by or on behalf of the Board to include Vizirgianakis for election at the 2024 Annual Meeting of Stockholders of the Company. In addition, Stavros Vizirgianakis stated that he agreed to cooperate to identify and add an additional new director to the Board after 6 months from the date of the Letter Agreement, subject to certain terms and conditions, and during the duration of the Letter Agreement, Vizirgianakis has agreed to vote in favor of the election of all the director nominees recommended for election by the Board and otherwise in accordance with the Board?s recommendation on all other proposals, subject to certain limited exceptions.